Complications associated with oncological therapy - how to minimize?
Main Authors: | Szczęśniak, Angelika, Serwin, Natalia, Cecerska-Heryć, Ela, Stangret, Anna, Mularczyk, Agata, Grzeszczak, Konrad, Topczewska, Katarzyna |
---|---|
Format: | Article eJournal |
Terbitan: |
, 2020
|
Online Access: |
https://zenodo.org/record/4026859 |
Daftar Isi:
- Szczęśniak Angelika, Serwin Natalia, Cecerska-Heryć Ela, Stangret Anna, Mularczyk Agata, Grzeszczak Konrad, Topczewska Katarzyna. Complications associated with oncological therapy - how to minimize? Journal of Education, Health and Sport. 2020;10(9):319-331. eISSN 2391-8306. DOI http://dx.doi.org/10.12775/JEHS.2020.10.09.036 https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/JEHS.2020.10.09.036 https://zenodo.org/record/4026859 The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019. © The Authors 2020; This article is published with open access at Licensee Open Journal Systems of Nicolaus Copernicus University in Torun, Poland Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author (s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non commercial license Share alike. (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited. The authors declare that there is no conflict of interests regarding the publication of this paper. Received: 20.08.2020. Revised: 25.08.2020. Accepted: 13.09.2020. Complications associated with oncological therapy - how to minimize? Angelika Szczęśniak1,a, Natalia Serwin1,b, Ela Cecerska-Heryć1,g, Anna Stangret2,c, Agata Mularczyk3,d, Konrad Grzeszczak4,e, Katarzyna Topczewska5,f 1Department of Laboratory Medicine, Pomeranian Medical University, Poland 2Department of Human and Clinical Anatomy, Pomeranian Medical University, Poland 3Department of Obstetrics and Pathology of Pregnancy, Pomeranian Medical University, Poland 4Department of Biology and Medical Parasitology, Pomeranian Medical University, Poland 5Department of Epidemiology and Management, Pomeranian Medical University, Poland ahttps://orcid.org/0000-0002-7854-8864 bhttps://orcid.org/0000-0002-1769-2037 chttps://orcid.org/0000-0002-2721-2121 dhttps://orcid.org/0000-0002-8273-6737 ehttps://orcid.org/0000-0002-3055-3357 fhttps://orcid.org/0000-0003-2509-8289 ghttps://orcid.org/0000-0002-7313-7193 Abstract During cancer therapy, patients undergo long-term treatment with chemotherapists. Unfortunately, although chemotherapy effectively destroys cancer cells, its toxicity may cause many adverse effects, weakening the patient's body. Their intensity is determined by many factors, including the age of the patient, the dose and type of drugs, the efficiency of metabolism and the occurrence of coexisting diseases. The most common side effects associated with chemotherapy include: myelosuppression, anaemia, neutropenia, thrombocytopenia, thrombocytopenia, thromboembolic disease, cardiovascular disorders, hair loss, nausea, diarrhoea, mucositis, taste change or fatigue. The complications that occur during or after chemotherapy are still a huge challenge for modern oncology. It is very important that the treatment of a patient with cancer is conducted by a team of doctors with many specializations. The individualization of treatment and the introduction of combined therapy may significantly minimize the occurrence of many serious complications, which may affect not only the quality of treatment, but also the patient life expectancy. Key words: chemotherapy, toxicity, pain treatment, oncology, disorders